Evidence map›Paper›PMID 39055196›Full record

ReviewFood science & nutrition2024

Review of the anticancer properties of 6-shogaol: Mechanisms of action in cancer cells and future research opportunities.

Gabriela Figueroa-González, Laura Itzel Quintas-Granados, Octavio Daniel Reyes-Hernández, Isaac H Caballero-Florán, Sheila I Peña-Corona, Hernán Cortés, Gerardo Leyva-Gómez, Solomon Habtemariam, Javad Sharifi-Rad

Abstract readReview
In one paragraph

Review in Food science & nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gabriela Figueroa-GonzálezLaboratorio de Farmacogenética, UMIEZ, Facultad de Estudios Superiores Zaragoza Universidad Nacional Autónoma de México Ciudad de México Mexico.
Laura Itzel Quintas-GranadosColegio de Ciencias y Humanidades, Plantel Cuautepec Universidad Autónoma de la Ciudad de México Ciudad de México Mexico.ORCID https://orcid.org/0000-0002-8622-2004
Octavio Daniel Reyes-HernándezLaboratorio de Biología Molecular del Cáncer, UMIEZ, Facultad de Estudios Superiores Zaragoza Universidad Nacional Autónoma de México Ciudad de México Mexico.
Isaac H Caballero-FloránDepartamento de Farmacia, Facultad de Química Universidad Nacional Autónoma de México Ciudad de México Mexico.
Sheila I Peña-CoronaDepartamento de Farmacia, Facultad de Química Universidad Nacional Autónoma de México Ciudad de México Mexico.
Hernán CortésLaboratorio de Medicina Genómica, Departamento de Genómica Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra Ciudad de Mexico Mexico.
Gerardo Leyva-GómezDepartamento de Farmacia, Facultad de Química Universidad Nacional Autónoma de México Ciudad de México Mexico.
Solomon HabtemariamPharmacognosy Research & Herbal Analysis Services UK Central Avenue, Chatham-Maritime Kent ME4 4TB UK.
Javad Sharifi-RadFacultad de Medicina Universidad del Azuay Cuenca Ecuador.ORCID https://orcid.org/0000-0002-7301-8151

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a major global health challenge that affects every nation and accounts for a large portion of the worldwide disease burden. Furthermore, cancer cases will rise significantly in the next few decades. The Food and Drug Administration has approved more than 600 drugs for treating diverse types of cancer. However, many conventional anticancer medications cause side effects, and drug resistance develops as the treatment proceeds with a concomitant impact on patients' quality of life. Thus, exploring natural products with antitumor properties and nontoxic action mechanisms is essential. Ginger (

Indexed as

6‐Shogaolcancerdrug resistanceginger

Identifiers

PMID39055196
PMCPMC11266911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.